The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Antidepressants are frequently prescribed in patients with psychotic disorders, but little is known about their effects in routine clinical practice. The objective was to investigate the prescribing patterns of antidepressants in relation to the course of depressive symptoms in patients with psychotic disorders. Methods: A cohort of 214 Dutch patients with psychotic disorders received two assessments of somatic and psychiatric health, including a clinician-rated screening for depressive symptoms, as part of annual routine outcome monitoring. Results: Depressive symptoms were prevalent among 43% (93) of the patients. Antidepressants were prescribed for 40% (86) of the patients and the majority 83% (71) continued this therapy after one year. Multivariable analysis showed that patients with more severe psychopathology had a higher risk to develop depressive symptoms the following year (OR [95% CI]=0.953 [0.912–0.995]). For patients with depressive symptoms at baseline, polypharmacy was a potential risk factor to keep having depressive symptoms (OR [95% CI]=1.593 [1.123–2.261]). Antidepressant use was not an independent predictor in both analyses. Conclusions: Routine outcome monitoring in patients with psychotic disorders revealed a high prevalence of depressive symptoms. Antidepressants were frequently prescribed and continued in routine clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Psychiatric Comorbidities and Schizophrenia
Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn135 · Cited by 1,121 · cited 1×
“Depressive symptoms occur in about 25% of patients with schizophrenia [10,44], but the reported prevalence may vary between 7 and 75% [15,19,20,26].”
BackgroundRelapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 1×
“Their antidepressant therapy may have served as an effective prophylaxis [16,21], for other indications such as negative symptoms or anxiety or it may indicate overprescribing.”
BackgroundBaynes, D., Mulholland, C., Cooper, S. J., Montgomery, R. C., MacFlynn, G., Lynch, G., Kelly, C., & King, D. J. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00205-4 · Cited by 136 · cited 2×
“Previous cross-sectional studies have shown that depressive symptoms are associated with more severe psychopathology and (related) polypharmacy [8,12,24,27,31,43].”
BackgroundResultKaymaz, N., van Os, J., Loonen, A. J. M., & Nolan, W. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0910 · Cited by 135 · cited 1×
“Their antidepressant therapy may have served as an effective prophylaxis [16,21], for other indications such as negative symptoms or anxiety or it may indicate overprescribing.”
BackgroundAntidepressants for people with both schizophrenia and depression
Whitehead, C., Moss, S., Cardno, A., Lewis, G., & Furtado, V. A. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002305 · Cited by 92 · cited 2×
“One of the reasons for the lack of detail in the guidelines is the scarcity of evidence about effectiveness of antidepressants in schizophrenia [28,47], but also for depression in general [22].”
BackgroundDepressive and negative symptoms in schizophrenia: different effects on clinical features
Rocca, P., Bellino, S., Calvarese, P., Marchiaro, L., Patria, L., Rasetti, R., & Bogetto, F. (2005) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2004.09.001 · Cited by 76 · cited 1×
“Also in accordance with previous studies, depressive symptoms were not associated with age, gender, duration of illness or being institutionalized [1,2,7,8,12,31,37].”
Result
Cited by
Depression and Schizophrenia: Cause, Consequence or Trans-diagnostic Issue?
Upthegrove, R., Marwaha, S., & Birchwood, M. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw097 · Cited by 400
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
IPS multicentric study: Antidepressant prescription patterns
Grover, S., Avasth, A., Kalita, K., Dalal, P., Rao, G., Chadda, R., Lakdawala, B., Bang, G., Chakraborty, K., Kumar, S., et al. (2013) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.105503 · Cited by 53
“When we compare the findings of the present study with that with those from other countries, similar trends of prescription of SSRIs have been reported from the West[7,10] and multi-country study from East Asia.”
ResultInfluentialLyngstad, S. H., Gardsjord, E. S., Engen, M. J., Haatveit, B., Ihler, H. M., Wedervang-Resell, K., Simonsen, C., Melle, I., & Færden, A. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01112-3 · Cited by 16
Lavaud, P., McMahon, K., Sánchez Rico, M., Hanon, C., Alvarado, J. M., de Raykeer, R. P., Limosin, F., & Hoertel, N. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2021.114339 · Cited by 16
Metadata
- Authors
- Lako, I. M., Taxis, K., Bruggeman, R., Knegtering, H., Burger, H., Wiersma, D., & Slooff, C. J.
- Venue
- European Psychiatry
- Publisher
- Cambridge University Press (CUP)
- Published
- 2012-05
- Volume
- 27
- Issue
- 4
- Pages
- 240-244
- ISSN
- 0924-9338 (ISSN-L)
- 1778-3585
- OpenAlex
- W2077209151
- Cited by
- 53
- References
- 7
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study. https://app.cochat.ai/papers/10.1016/j.eurpsy.2010.10.007
- The paper
- Lako, I. M., Taxis, K., Bruggeman, R., Knegtering, H., Burger, H., Wiersma, D., & Slooff, C. J. (2012). The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2010.10.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.